Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Organisation › Details

Ori Biotech (Oribiotech) (Group)

Ori is a London-and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies. Ori has developed a proprietary, full stack manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to develop and bring their products to market at commercial scale. The promise of the innovative Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics. Ori was founded in 2015 by Dr. Farlan Veraitch (UCL) and has brought together a seasoned Board and management team with over 200 years of combined pharmaceutical, CGT and venture building experience including CEO Jason C. Foster (Indivior), CBO Jason Jones (Miltenyi), CDOO Kevin Gordon (Tmunity), CTO Stuart Milne (Cytiva), VP Tom Heathman (Minaris), VP David Smith (Minaris), VP Lee Unroe (Indivior), Chris Mason (AVROBIO), Paul Meister (ThermoFisher) and Annalisa Jenkins (Dimension Therapeutics) alongside expert advisers like Bruce Levine, Anthony Davies, and Robert Preti. *

 

Period Start 2015-09-02 established
  Today Oribiotech Ltd. (d/b/a Ori Biotech)
Products Industry cell therapy manufacturing/processing technology
  Industry 2 gene therapy manufacturing/processing technology
Persons Person Foster, Jason C. (Oribiotech 202001– CEO)
  Person 2 Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder)
     
Region Region London, Greater London
  Country United Kingdom (GB)
  Street Beaufort Court Admirals Way
South Quay Waterside
  City E14 9XL London
    Address record changed: 2023-07-10
     
Basic data Employees n. a.
     
    * Document for »About Section«: Ori Biotech Ltd.. (1/18/22). "Press Release: Ori Biotech Raises over $100 Million in Series B Funding to Launch Innovative Cell and Gene Therapy Manufacturing Platform". London.
     
   
Record changed: 2024-06-07

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x200px

More documents for Ori Biotech (Oribiotech) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top